FDA Restricts Sales of Bayer’s Essure Contraceptive Implant

FDA Restricts Sales of Bayer’s Essure Contraceptive Implant  New York Times US FDA restricts sale of Bayer’s Essure birth control device  Reuters FDA Adds Restrictions on Sale of Bayer’s Essure  Wall Street Journal FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information  FDA.gov Full coverage

from Business – Google News https://www.nytimes.com/2018/04/09/health/fda-essure-bayer-contraceptive-implant.html

Advertisements